Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Scientists have uncovered critical differences between how innate-like T cells mature in humans and mice. Early in life, most innate-like T cells in the human thymus aren't able to use all of their ...

PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS ...

The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and ...

Two new therapies have successfully cleared tau aggregates in preclinical and mouse models, showing potential as dementia ...

A biomarker of eight microRNAs forms a "fingerprint" of ALS in the blood, which can be detected with 98% accuracy in a ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that preclinical ...

The option gives Glaukos exclusive global license agreements on pre-agreed terms, including upfront and milestone payments ...

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease Prescreening rate of Phase 2b ReTain trial triggers clinical ...

Late-breaking oral presentation will discuss the potential of ZL-1503 as a novel treatment for moderate-to-severe atopic ...

Since this month of September, the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University is ...